There were no statistically significant differences between aspirin and triflusal concerning new vascular events ( @ vs. @ % ; p = @ ) , stroke recurrence ( @ vs. @ % ; p = @ ) , ischemic heart events ( @ vs. @ % ; p = @ ) , vascular death ( @ vs. @ % ; p = @ ) and global mortality ( @ vs. @ % ; p = @ ) .